Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record, with a small difference in title or year; 54 of the 55 references it cites were found in a registry or an index.

The Funny Current: Cellular Basis for the Control of Heart Rate

Abstract

The 'funny' (pacemaker, I(f)) current, first described almost 30 years ago in sinoatrial node (SAN) myocytes, is a mixed sodium/potassium inward current, activated on hyperpolarisation in the diastolic range of voltages. 'Funny' (f) channels are activated by intracellular cyclic adenosine monophosphate (cAMP) concentrations according to a mechanism mediating regulation of heart rate by the autonomic nervous system, as well as by voltage hyperpolarisation. Structural subunits of native f-channels are the hyperpolarisation-activated cyclic nucleotide-gated (HCN) channels; of the four HCN isoforms known, HCN4 is the most highly expressed in SAN tissue. The I(f) current is a natural target in the search for drugs aimed specifically at affecting heart rate, given its function in pacemaking. Increased heart rate has a negative influence on clinical outcome in patients with cardiovascular disease, and indeed is also an established risk factor for cardiovascular and all-cause mortality in the general population. Clearly, therefore, independent reduction of heart rate, through inhibition of the I(f) current, appears to be a suitable therapeutic option for patients with ischaemic heart disease.beta-Adrenoceptor antagonists (beta-blockers) reduce intracellular cAMP levels, and a substantial part of their negative chronotropic effect is therefore attributable to a reduction of the I(f) current. However, neither beta-blockers nor Ca(2+) channel antagonists, both of which have traditionally been used to reduce myocardial ischaemia, are 'pure' heart rate-lowering drugs. These agents may, in fact, have adverse cardiovascular and noncardiovascular effects.Conversely, the novel heart rate-reducing agent ivabradine is a specific blocker of f-channels, hence a selective inhibitor of the pacemaker I(f) current in the SAN. Ivabradine slows heart rate by reducing the I(f) current-regulated steepness of the diastolic depolarisation in SAN myocytes, thereby increasing diastolic duration, without altering action potential duration or causing negative inotropy. As such, ivabradine is particularly useful in patients with chronic stable angina pectoris. Further clinical studies are ongoing to evaluate the efficacy of ivabradine in patients with coronary heart disease, left ventricular dysfunction and heart failure. This short article reviews the current state of knowledge of the properties of the 'funny' current in relation to exploitation of the I(f) function in pacemaking generation and modulation for the pharmacological control of heart rate.

Overview

Integrity signals

Registry

Crossref · 10.2165/00003495-200767002-00003

Cites

54 of 54 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 55 references

Research works printed but not linked: 6

  1. Ferrari, 2002, Medicographia, 24, 201
  2. Diaz, 2005, Medicographia, 27, 82
  3. Lipsius, 2001, News Physiol Sci, 16, 101
  4. DiFrancesco, 2002, Medicographia, 24, 218
  5. Borer, 2005, Medicographia, 27, 44
  6. Purcell, 2005, Medicographia, 27, 51

Cited by

See all 155

Metadata

Authors
DiFrancesco, D., & Borer, J. S.
Affiliations
  • University of Milan (IT)
  • NewYork–Presbyterian Hospital (US)
Corresponding author
DiFrancesco, Dario
Venue
Drugs
Published
2007
Volume
67
Issue
Supplement 2
Pages
15-24
ISSN
0012-6667 (ISSN-L)
OpenAlex
W2066304445
Cited by
155
References
55
Citations by year
2026: 6 · 2025: 5 · 2024: 7 · 2023: 4 · 2022: 7 · 2021: 9 · 2020: 8 · 2019: 12 · 2018: 13 · 2017: 12 · 2016: 7 · 2015: 8 · 2014: 4 · 2013: 8 · 2012: 8
FWCI
6.55
Type
journal article
Language
en
Open access
closed
Locations
  • Drugs (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Rate Variability and Autonomic Control
Keywords
hyperpolarization-activated current, HCN channels, HCN4, sinoatrial node, pacemaking, rate control, ivabradine, beta-blockers, negative chronotropic effect, ischemic heart disease, stable angina, cyclic AMP
MeSH terms
Ivabradine, Cyclic AMP, Animals, Benzazepines, Electrophysiology, Heart Rate, Humans, Muscle Proteins, Sinoatrial Node, Potassium Channels, Myocardial Ischemia, Protein Isoforms, Myocytes, Cardiac, Cyclic Nucleotide-Gated Cation Channels, Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Funny Current: Cellular Basis for the Control of Heart Rate. https://app.cochat.ai/papers/10.2165/00003495-200767002-00003
The paper
DiFrancesco, D., & Borer, J. S. (2007). The Funny Current: Cellular Basis for the Control of Heart Rate. Drugs. https://doi.org/10.2165/00003495-200767002-00003

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.